Do peripheral neuropathies differ among immune checkpoint inhibitors? Reports from the European post-marketing surveillance database in the past 10 years

Do peripheral neuropathies differ among immune checkpoint inhibitors? Reports from the European post-marketing surveillance database in the past 10 years

Although the immunotherapy advent has revolutionized cancer treatment, it, unfortunately, does not spare cancer patients from possible immune-related adverse events (irAEs), which can also involve the peripheral nervous system. Immune checkpoint inhibitors (ICIs), blocking cytotoxic T-lymphocyteasso...

Full description

Bibliographic Details
Main Authors: Rosanna Ruggiero, Nunzia Balzano, Raffaella Di Napoli, Federica Fraenza, Ciro Pentella, Consiglia Riccardi, Maria Donniacuo, Marina Tesorone, Romano Danesi, Marzia Del Re, Francesco Rossi, Annalisa Capuano
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Immunology
Subjects:
immune checkpoint inhibitors
neurological toxicity
immune-related adverse events
immunotherapy
post-marketing surveillance
translational research
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1134436/full

Similar Items

Similar Items